Hispanic patients evaluated for frontotemporal dementia in South Texas arrived at specialty care an average of four years after their first symptoms, and presented with more movement-related symptoms and more advanced cognitive impairment than non-Hispanic white patients, according to a study published online on 23 July 2026 in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. The paper, first-authored by Shannon B. Lavigne, now at the University of Kansas School of Medicine-Wichita, with A. Campbell Sullivan of the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases as senior author, drew on 41 Hispanic and 429 non-Hispanic white participants in total. Public radio station TPR, reporting on the work, said delays in the group studied ran as long as 10 years.
The design is observational and cross-sectional, not a trial. The researchers combined a regional group of 17 Hispanic and 22 non-Hispanic white participants seen through the Biggs Institute FTD Center, the South Texas Alzheimer's Disease Research Center and the locally housed ALLFTD cohort, then compared them with 24 Hispanic and 407 non-Hispanic white participants in the National Alzheimer's Coordinating Center dataset, harmonising clinical, neuroimaging and neuropsychological data across the cohorts. The authors report that Hispanic participants more often showed movement changes at presentation while non-Hispanic white participants more often showed the behavioural changes classically associated with the disease, and that neurodegenerative syndromes were under-recognised, with referral to neurology often coming only after marked decline in communication, behaviour and cognition. Educational disparities, the authors conclude, contributed significantly to differences in health care access.
Frontotemporal dementia is a group of neurodegenerative disorders affecting personality and behaviour, speech and language, and movement. Onset is typically in midlife and it is the leading cause of dementia in people under 65, with the behavioural variant accounting for nearly half of cases. Hispanic participants have been thinly represented in the field: fewer than 5 percent of participants in the largest United States dataset on the disease are Hispanic, a gap Sullivan has argued becomes self-reinforcing, because the assumption that the disease does not occur in Hispanic populations itself delays recognition. In a statement issued by UT Health San Antonio, Sullivan said the findings underscore "diagnostic severity and systemic barriers faced by Hispanic populations with FTD".
The counterpoint is in the numbers themselves. Forty-one Hispanic participants, half of them from a single regional centre, is a small sample from which to read national patterns, and both the clinic series and the NACC dataset are made up of people who already reached a specialist, which is not the same as a population. A clinic-based comparison can show who arrives late and how sick they are on arrival; it cannot measure how many people in a community have the disease.